Vivos Therapeutics (VVOS) Gross Margin Growth (1y) (2021 - 2026)
Vivos Therapeutics (VVOS) Gross Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.32 Bn | 174.03 Bn | 6.27 Bn | -67.00 |
| 2 | Stryker | 128.59 Bn | 125.71 Bn | 3.81 Bn | -54.00 |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 60.00 |
| 4 | Boston Scientific | 67.77 Bn | 66.32 Bn | 3.61 Bn | 62.00 |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.46 Bn | 1.29 Bn | -65.00 |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.15 Bn | 1.98 Bn | -359.00 |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 610.00 |
| 8 | Smith & Nephew | 26.77 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.24 Bn | 22.11 Bn | 2.07 Bn | 9.00 |
| 10 | Vivos Therapeutics | 6.07 Mn | 3.96 Mn | 3.06 Mn | 947.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 947.00 |
| Dec 31, 2025 | 2,143.00 |
| Sep 30, 2025 | -242.00 |
| Jun 30, 2025 | -1,016.00 |
| Mar 31, 2025 | -662.00 |
| Dec 31, 2024 | -761.00 |
| Sep 30, 2024 | 754.00 |
| Jun 30, 2024 | 360.00 |
| Mar 31, 2024 | -394.00 |
| Dec 31, 2023 | 396.00 |
| Sep 30, 2023 | -586.00 |
| Jun 30, 2023 | -6.00 |
| Mar 31, 2023 | -941.00 |
| Dec 31, 2022 | -1,036.00 |
| Sep 30, 2022 | -1,123.00 |
| Jun 30, 2022 | -1,873.00 |
| Mar 31, 2022 | -801.00 |
| Dec 31, 2021 | -1,059.00 |
| Sep 30, 2021 | -844.00 |
| Jun 30, 2021 | -276.00 |